Introducing the Adeno Rapid Diagnostic Test, a revolutionary development in the field of biotechnology by QL Biotech. This advanced test device is designed to detect the presence of antibodies reacting to HIV 1&2 and the P24 antigen. It operates on a qualitative membrane-based immunoassay method which allows the device to be compatible with various sample types including whole blood, serum, and plasma. Our Adeno Rapid Diagnostic Test is a testament to our commitment to empowering medical professionals and patients with quick, reliable diagnostic tools. The science behind this test revolves around the detection of HIV antibodies and P24 antigen in the applied sample, making it a valuable tool in diagnosing and monitoring HIV infections. It is designed for efficiency and accuracy, ensuring the generation of dependable results for informed decision-making.

• ● Test devices 
  ● Disposable specimen droppers 
  ● Buffer 
  ● Package insert 
  Materials Required But Not Provided 
  ● Specimen collection containers 
  ● Lancets (for fingerstick whole blood only) 
  ● Centrifuge (for plasma only) 
  ● Timer 
  ● Disposable heparinized capillary tubes and dispensing bulb (for fingerstick whole blood only)

Sensitivity

Human Immunodeficiency Virus (HIV) Ab & P24 Ag Rapid Test Device (Whole

Blood/Serum/Plasma) has been tested by anti-HIV 1 low titer performance panel, anti-HIV 2 performance panel and anti-HIV 1 seroconversion panel (Boston Biomedica, Inc.). And it has also been compared with leading commercial EIA HIV test on clinical specimens. The results show that

HIV 1&2 Human Immunodeficiency Virus Rapid Test Device (Whole Blood/Serum/Plasma) is very sensitive to HIV 1 and/or HIV 2 antibodies.

Specificity

The specificity of the test is comparable to a leading commercial HIV EIA test. Human Immunodeficiency Virus (HIV) Ab & P24 Ag Rapid Test Device (Whole Blood/Serum/Plasma) is highly specific for anti-HIV 1 and/or HIV 2 compared to a leading commercial HIV EIA test.

Relative Sensitivity: 99.9% (99.3%-100.0%)*Relative Specificity: 99.6% (99.1%-99.9%)*

Relative Accuracy: 99.8% (99.4%-99.9%)* * 95% Confidence Interval

Precision

Intra Assay

Within-run precision has been determined by using 15 replicates of three specimens: a negative, a low positive and a high positive. The negative, low positive and high positive values were correctly identified 99.5% of the time.

Inter-Assay

Between-run precision has been determined by 15 independent assays on the same three specimens: a negative, a low positive and a high positive. Three different lots of Human

Immunodeficiency Virus (HIV) Ab & P24 Ag Rapid Test Device (Whole Blood/Serum/Plasma) have been tested using negative, low positive and high positive specimens. The specimens were correctly identified 99.5% of the time.

 

The core principle of the Adeno Rapid Diagnostic Test involves the use of a membrane-based immunoassay, a technique renowned for its highly sensitive detection capabilities. This cutting-edge testing methodology enables the rapid detection of antibodies and antigens, providing results that form the crux of medical diagnosis and subsequent treatment plans. To sum up, our Adeno Rapid Diagnostic Test offers a dependable solution for rapid HIV diagnostics. Its versatile compatibility with multiple types of samples —whole blood, serum, and plasma— underscores its practicality in diverse testing situations. With its qualitative detection capabilities, it stands as a beacon of hope and a significant step forward in combating HIV. Trust the Adeno Rapid Diagnostic Test from QL Biotech for rapid and reliable HIV diagnostics.